HK1109594A1 - Improved quenching methods for red blood cell inactivation process - Google Patents
Improved quenching methods for red blood cell inactivation processInfo
- Publication number
- HK1109594A1 HK1109594A1 HK08103739.2A HK08103739A HK1109594A1 HK 1109594 A1 HK1109594 A1 HK 1109594A1 HK 08103739 A HK08103739 A HK 08103739A HK 1109594 A1 HK1109594 A1 HK 1109594A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- red blood
- blood cell
- methods
- improved
- quencher
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 210000003743 erythrocyte Anatomy 0.000 title abstract 3
- 238000010791 quenching Methods 0.000 title abstract 3
- 230000000171 quenching effect Effects 0.000 title abstract 3
- 230000002779 inactivation Effects 0.000 title 1
- 125000000524 functional group Chemical group 0.000 abstract 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 glutathione Chemical class 0.000 abstract 1
- 229960003180 glutathione Drugs 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000000269 nucleophilic effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000007086 side reaction Methods 0.000 abstract 1
- 150000003573 thiols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62317704P | 2004-10-29 | 2004-10-29 | |
PCT/US2005/039392 WO2006050328A1 (fr) | 2004-10-29 | 2005-10-31 | Procedes d'inhibition ameliores destines a un processus d'inactivation de globules rouges |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1109594A1 true HK1109594A1 (en) | 2008-06-13 |
Family
ID=35789172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08103739.2A HK1109594A1 (en) | 2004-10-29 | 2008-04-02 | Improved quenching methods for red blood cell inactivation process |
Country Status (13)
Country | Link |
---|---|
US (1) | US7655392B2 (fr) |
EP (1) | EP1838355B1 (fr) |
JP (3) | JP5346468B2 (fr) |
CN (2) | CN101094692A (fr) |
AU (2) | AU2005302256B2 (fr) |
BR (1) | BRPI0518198B8 (fr) |
CA (1) | CA2585621C (fr) |
DK (1) | DK1838355T3 (fr) |
ES (1) | ES2429088T3 (fr) |
HK (1) | HK1109594A1 (fr) |
PL (1) | PL1838355T3 (fr) |
PT (1) | PT1838355E (fr) |
WO (1) | WO2006050328A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69826521T2 (de) * | 1998-01-06 | 2005-09-29 | Cerus Corp., Concord | Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien |
DK1838355T3 (da) | 2004-10-29 | 2013-10-28 | Cerus Corp | Forbedrede quenching-fremgangsmåder til erytrocyt-inaktiveringsfremgangsmåde |
AU2009233807B2 (en) * | 2008-04-09 | 2014-11-27 | Cerus Corporation | Improved quenching methods for red blood cell pathogen inactivation |
US11284616B2 (en) | 2010-05-05 | 2022-03-29 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
US9199016B2 (en) | 2009-10-12 | 2015-12-01 | New Health Sciences, Inc. | System for extended storage of red blood cells and methods of use |
US7989593B1 (en) | 2010-05-27 | 2011-08-02 | Bing Lou Wong | Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
US8048856B1 (en) | 2010-06-23 | 2011-11-01 | Billion King, Ltd. | Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition |
US7932356B1 (en) | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
US8084581B1 (en) | 2011-04-29 | 2011-12-27 | Bing Lou Wong | Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus |
US20130052232A1 (en) | 2011-08-31 | 2013-02-28 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
US20160081328A1 (en) * | 2013-05-10 | 2016-03-24 | President And Fellows Of Harvard College | Solutions for Red Blood Cells |
EA201790265A1 (ru) | 2014-07-23 | 2017-07-31 | Сирус Корпорейшн | Способы получения тромбоцит-содержащих продуктов |
IL299978B1 (en) | 2015-03-10 | 2024-04-01 | Hemanext Inc | Single-use oxygen reduction kits, devices and methods for their use |
KR20240067253A (ko) | 2015-04-23 | 2024-05-16 | 헤마넥스트 인코포레이티드 | 혐기성 혈액 저장 용기 |
MX2017014812A (es) | 2015-05-18 | 2018-05-11 | New Health Sciences Inc | Metodos para el almacenamiento de sangre completa y composiciones de esta. |
CN108135936A (zh) | 2015-06-26 | 2018-06-08 | 塞鲁斯公司 | 冷沉淀物组合物及其制备方法 |
CA3003097A1 (fr) | 2015-10-23 | 2017-04-27 | Cerus Corporation | Compositions de plasma et leurs procedes d'utilisation |
CN109195632A (zh) * | 2016-05-27 | 2019-01-11 | 新健康科学股份有限公司 | 厌氧血液储存和病原体失活方法 |
WO2018119462A1 (fr) | 2016-12-23 | 2018-06-28 | Cerus Corporation | Systèmes et procédés de test et de criblage utilisant des substrats liés à un composé |
US20190321407A1 (en) * | 2016-12-31 | 2019-10-24 | Cerus Corporation | Compositions and methods for preparation of red blood cells |
AU2018227586B2 (en) | 2017-03-03 | 2023-12-21 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
AU2018338097B2 (en) | 2017-09-20 | 2023-07-13 | Cerus Corporation | Compositions and methods for pathogen inactivation of platelets |
EA202091602A1 (ru) | 2017-12-29 | 2020-10-19 | Сирус Корпорейшн | Системы и способы для обработки биологических жидкостей |
CA3107314A1 (fr) * | 2018-07-27 | 2020-01-30 | Zata Pharmaceuticals, Inc. | Procede d'inactivation de pathogenes, de microorganismes et de parasites |
EA202190810A1 (ru) * | 2018-09-20 | 2021-08-23 | Сирус Корпорейшн | Способы и наборы для получения цельной крови с инактивированным патогеном |
MX2021015653A (es) | 2019-06-22 | 2022-04-11 | Cerus Corp | Sistemas de tratamiento de fluidos biologicos. |
US11883544B2 (en) | 2019-06-28 | 2024-01-30 | Cerus Corporation | System and methods for implementing a biological fluid treatment device |
EP4240757A2 (fr) | 2020-11-09 | 2023-09-13 | Takeda Pharmaceutical Company Limited | Purification de fviii à partir du plasma au moyen d'une adsorption d'oxyde de silicium |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2402665A (en) | 1942-11-12 | 1946-06-25 | Du Pont | Chemical process |
IT1093275B (it) | 1978-01-26 | 1985-07-19 | Snam Progetti | Composizione adatta alla purificazione del sangue e suoi impieghi |
US4337269A (en) | 1979-07-23 | 1982-06-29 | Sutton Laboratories, Inc. | Preservative compositions |
US4748120A (en) | 1983-05-02 | 1988-05-31 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
US4727027A (en) | 1983-05-02 | 1988-02-23 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
US5281579A (en) | 1984-03-23 | 1994-01-25 | Baxter International Inc. | Purified virus-free hemoglobin solutions and method for making same |
US4971760A (en) | 1986-03-10 | 1990-11-20 | University Of Southern California | Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae |
US4944920A (en) | 1986-08-01 | 1990-07-31 | University Of Southern California | Novel method to treat blood |
US4920143A (en) | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US5094960A (en) | 1988-10-07 | 1992-03-10 | New York Blood Center, Inc. | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography |
US5055485A (en) | 1988-12-02 | 1991-10-08 | New York Blood Center, Inc. | Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides |
US5587490A (en) | 1990-04-16 | 1996-12-24 | Credit Managers Association Of California | Method of inactivation of viral and bacterial blood contaminants |
US5418130A (en) | 1990-04-16 | 1995-05-23 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
US5232844A (en) | 1990-05-15 | 1993-08-03 | New York Blood Center | Photodynamic inactivation of viruses in cell-containing compositions |
US5120649A (en) | 1990-05-15 | 1992-06-09 | New York Blood Center, Inc. | Photodynamic inactivation of viruses in blood cell-containing compositions |
US5658722A (en) | 1990-05-15 | 1997-08-19 | New York Blood Center, Inc. | Process for the sterilization of biological compositions using UVA1 irradiation |
US5753258A (en) | 1990-10-19 | 1998-05-19 | University Of Florida | Artificial viral envelopes |
GB9218581D0 (en) | 1992-09-02 | 1992-10-14 | Pall Corp | Removal of unwanted fluids from processed blood products |
ZA944488B (en) | 1993-06-23 | 1995-02-15 | New York Blood Center Inc | System for viral inactivation of blood |
US5591350A (en) | 1994-04-15 | 1997-01-07 | Pall Corporation | Iodine disinfection method using a gaseous iodine treated porous medium |
SE9402472L (sv) | 1994-07-13 | 1996-01-14 | Forskarpatent I Linkoeping Ab | Modifierade ytor |
US5522385A (en) | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
US5660731A (en) | 1994-11-08 | 1997-08-26 | Pall Corporation | Filter for separating photoactive agent |
US5691132A (en) | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
US5637451A (en) | 1995-03-29 | 1997-06-10 | New York Blood Center, Inc. | Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells |
US6177441B1 (en) | 1995-06-05 | 2001-01-23 | Cerus Corporation | Treating red blood cell solutions with anti-viral agents |
ES2337852T3 (es) | 1995-06-07 | 2010-04-29 | Cerus Corporation | Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos. |
US20020192632A1 (en) | 1995-06-07 | 2002-12-19 | Hei Derek J. | Method and devices for the removal of psoralens from blood products |
WO1996039816A1 (fr) | 1995-06-07 | 1996-12-19 | Baxter International Inc. | Procede d'inactivation de contaminants viraux et bacteriens dans le sang |
US6544727B1 (en) | 1995-06-07 | 2003-04-08 | Cerus Corporation | Methods and devices for the removal of psoralens from blood products |
EP0773716A4 (fr) | 1995-06-07 | 1999-08-04 | Cerus Corp | Traitement de solutions de globules rouges par des agents antiviraux |
WO1997002028A1 (fr) | 1995-06-29 | 1997-01-23 | Hemasure, Inc. | Inactivation d'agents pathogenes par utilisation d'hydroxymethylamines |
US6114108A (en) | 1995-08-29 | 2000-09-05 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of viral nucleic acids |
US6136586A (en) | 1995-08-29 | 2000-10-24 | Vi Technologies, Inc. | Methods for the selective modification of viral nucleic acids |
WO1997016966A1 (fr) | 1995-11-06 | 1997-05-15 | New York Blood Center, Inc. | Traitement pour inactiver des virus effectue sur des globules rouges, en utilisant des phtalocyanines et une lumiere rouge |
AU1085697A (en) | 1995-11-21 | 1997-06-11 | Pall Corporation | Inactivation method and system in biological fluids |
US6514987B1 (en) | 1997-01-06 | 2003-02-04 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US20010018179A1 (en) | 1998-01-06 | 2001-08-30 | Derek J. Hei | Batch devices for the reduction of compounds from biological compositions containing cells and methods of use |
US20010009756A1 (en) | 1998-01-06 | 2001-07-26 | Derek Hei | Flow devices for the reduction of compounds from biological compositions and methods of use |
AU744089C (en) | 1997-01-06 | 2003-07-31 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US6093725A (en) | 1997-01-06 | 2000-07-25 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US6093564A (en) | 1997-10-03 | 2000-07-25 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
DE69826521T2 (de) | 1998-01-06 | 2005-09-29 | Cerus Corp., Concord | Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien |
US6277337B1 (en) * | 1998-07-21 | 2001-08-21 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
US6150109A (en) | 1999-01-25 | 2000-11-21 | V. I. TECHNOLOGIES, Inc. | Lipophilic quenching of viral inactivating agents |
EP1284743A2 (fr) * | 2000-05-31 | 2003-02-26 | Cerus Corporation | Preparation d'une solution de globules rouges a antigenicite reduite contenant des agents pathogenes inactives |
CN100417325C (zh) * | 2000-11-04 | 2008-09-10 | 王祥文 | 卫生灭菌消毒剂 |
EP1365750A2 (fr) * | 2000-12-21 | 2003-12-03 | Cerus Corporation | Procedes d'inactivation de pathogenes dans des matieres biologiques |
CN1186099C (zh) * | 2001-12-13 | 2005-01-26 | 孙岩军 | 麻醉机呼吸回路清洗消毒的方法及其操作步骤 |
DK1838355T3 (da) | 2004-10-29 | 2013-10-28 | Cerus Corp | Forbedrede quenching-fremgangsmåder til erytrocyt-inaktiveringsfremgangsmåde |
-
2005
- 2005-10-31 DK DK05821102.0T patent/DK1838355T3/da active
- 2005-10-31 US US11/264,195 patent/US7655392B2/en active Active
- 2005-10-31 WO PCT/US2005/039392 patent/WO2006050328A1/fr active Application Filing
- 2005-10-31 PL PL05821102T patent/PL1838355T3/pl unknown
- 2005-10-31 CN CNA2005800453138A patent/CN101094692A/zh active Pending
- 2005-10-31 PT PT58211020T patent/PT1838355E/pt unknown
- 2005-10-31 CA CA2585621A patent/CA2585621C/fr active Active
- 2005-10-31 EP EP05821102.0A patent/EP1838355B1/fr active Active
- 2005-10-31 CN CN201410112134.2A patent/CN103961731B/zh active Active
- 2005-10-31 BR BRPI0518198A patent/BRPI0518198B8/pt not_active IP Right Cessation
- 2005-10-31 JP JP2007539281A patent/JP5346468B2/ja active Active
- 2005-10-31 AU AU2005302256A patent/AU2005302256B2/en not_active Ceased
- 2005-10-31 ES ES05821102T patent/ES2429088T3/es active Active
-
2008
- 2008-04-02 HK HK08103739.2A patent/HK1109594A1/xx unknown
-
2011
- 2011-04-06 AU AU2011201554A patent/AU2011201554B2/en not_active Ceased
-
2012
- 2012-03-07 JP JP2012050837A patent/JP5718840B2/ja active Active
-
2013
- 2013-09-27 JP JP2013200906A patent/JP2013256537A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP5346468B2 (ja) | 2013-11-20 |
ES2429088T3 (es) | 2013-11-13 |
BRPI0518198B8 (pt) | 2021-06-22 |
AU2011201554B2 (en) | 2012-04-26 |
CA2585621C (fr) | 2015-12-15 |
PT1838355E (pt) | 2013-11-07 |
EP1838355A1 (fr) | 2007-10-03 |
JP2012107068A (ja) | 2012-06-07 |
JP2008518952A (ja) | 2008-06-05 |
BRPI0518198B1 (pt) | 2018-11-21 |
CA2585621A1 (fr) | 2006-05-11 |
DK1838355T3 (da) | 2013-10-28 |
PL1838355T3 (pl) | 2014-01-31 |
WO2006050328A1 (fr) | 2006-05-11 |
JP5718840B2 (ja) | 2015-05-13 |
AU2005302256B2 (en) | 2011-01-20 |
US20060115466A1 (en) | 2006-06-01 |
CN103961731A (zh) | 2014-08-06 |
AU2011201554A1 (en) | 2011-04-28 |
CN103961731B (zh) | 2017-01-18 |
CN101094692A (zh) | 2007-12-26 |
EP1838355B1 (fr) | 2013-08-14 |
AU2005302256A1 (en) | 2006-05-11 |
JP2013256537A (ja) | 2013-12-26 |
US7655392B2 (en) | 2010-02-02 |
BRPI0518198A (pt) | 2008-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1109594A1 (en) | Improved quenching methods for red blood cell inactivation process | |
ATE276771T1 (de) | Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien | |
WO2005078097A3 (fr) | Inhibition induite par l'interference arn de l'expression genetique, a l'aide d'un acide nucleique interferant court multifonctionnel (sina multifonctionnel) | |
WO2005040180A3 (fr) | Modulation antisens de l'expression de la superoxyde dismutase 1 soluble (sod-1) | |
MX2010010151A (es) | Moduladores de cinasa aurora y metodo de uso. | |
TNSN06059A1 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
WO2003000707A8 (fr) | Modulation anti-sens de l'expression de la superoxyde dismutase 1 soluble | |
HRP20030688B1 (hr) | Arilni i heteroarilni urea chk1 inhibitori za uporabu kao poticajne tvari radiosensitizatori i kemosensitizatori | |
WO2002020500A3 (fr) | Substances potentialisant un traitement anticancereux et methodes a cet effet | |
GB0417487D0 (en) | Organic compound | |
HK1197656A1 (zh) | 糖原累積病 型的療法 | |
WO2004106495A3 (fr) | Compositions, kits et procedes d'identification, d'evaluation et de prevention, et therapie anticancereuse | |
ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
WO2004087965A3 (fr) | Analyse statistique de sites de liaison de facteur regulateur de genes d'expression differentielle | |
HK1078593A1 (en) | Antibody against a tumor-specific antigen as target | |
WO2004009024A3 (fr) | Modulation de l'expression de la proteine kinase c-iota | |
DE602005026811D1 (de) | Verfahren zur inhibierung von tumorzellwachstum mit foxm1 sirns | |
WO2003030725A3 (fr) | Diagnostic et therapies d'un cancer du pancreas | |
WO2004009112A8 (fr) | Utilisation d'urease pour inhiber la croissance de cellules cancereuses | |
WO2003076610A3 (fr) | Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations | |
WO2004085614A3 (fr) | Molecules d'acides nucleiques a regulation differentielle dans un trouble bipolaire et leurs utilisations | |
UA93538C2 (en) | Aurora kinase modulators and method of use | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
WO2006014706A3 (fr) | Derives de methotrexate utilises pour traiter le cancer et l'arthrite | |
WO2005006958A8 (fr) | Modulation de l'expression de ceacam1 |